drugset / Trial / NCT03242317

A Prospective Study to Evaluate the Raindrop Near Vision Inlay With Mitomycin C

NCT03242317

Phase 4 Unknown 40 enrolled Fichte, Endl & Elmer Eyecare
NaSingle-groupOpen-labelPrevention

Summary

The objective of this study is to evaluate the Raindrop® Near Vision Inlay for the improvement of near vision in presbyopes treated with low dose, short duration Mitomycin C (MMC) during surgery and an extended low dose steroid regimen after surgery.

Timeline

Start
2017-06-16
Primary completion
2020-09-01
Completion
2020-12-01

Drugs

EvaluationDrugModalityDoseRoute
Background Mitomycin C Other / unclassified 0.2 mg/ml

Indications